Email This Article
Headlines & Perspectives
Biotech Mailbag: Who Will Run FDA?
By
Adam Feuerstein
11/07/08 - 04:05 PM EST
The FDA is in turmoil. Morale is low, resources are scarce and too many drug approvals have been delayed at best, or at worst, have become politicized. A look at some options to run the agency in the Obama administration.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,452.00 | 1,107.93 | 2,201.05 | 35.96 |
Oil *
72.90
|
|
DOWN
49.05
|
DOWN
6.18
|
DOWN
11.05
|
DOWN
0.07
|
10 Yr
3.60%
SPDR Gold
110.21
|
|
-0.47%
|
-0.55%
|
-0.50%
|
-0.19%
|
Data delayed 20 minutes |


Connect with TheStreet